Evidence map›Paper›PMID 31175458›Full record

ArticleWorld journal of urology2020

Effects of the addition of quantitative apparent diffusion coefficient data on the diagnostic performance of the PI-RADS v2 scoring system to detect clinically significant prostate cancer.

Marcia Oliveira Moraes, Diego H H Roman, Josenel Copetti, Francisco de S Santos, Alexandre Agra, Jorge A P Noronha, Gustavo Carvalhal, Eurico J Dornelles Neto, Matheus Zanon, Matteo Baldisserotto and 1 more

Open access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in World journal of urology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 2 pooled it
1.0field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 2 syntheses or guidelines pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Quantitative Prostate MRI, From theAJR. American journal of roentgenology · 2025
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Marcia Oliveira MoraesDepartment of Radiology, Pontificia Universidade Católica Do Rio Grande Do Sul, Av. Ipiranga, 6681, Porto Alegre, 90619900, Brazil.
Diego H H RomanDepartment of Radiology, Pontificia Universidade Católica Do Rio Grande Do Sul, Av. Ipiranga, 6681, Porto Alegre, 90619900, Brazil.
Josenel CopettiDepartment of Radiology, Pontificia Universidade Católica Do Rio Grande Do Sul, Av. Ipiranga, 6681, Porto Alegre, 90619900, Brazil.
Francisco de S SantosDepartment of Radiology, Pontificia Universidade Católica Do Rio Grande Do Sul, Av. Ipiranga, 6681, Porto Alegre, 90619900, Brazil.
Alexandre AgraDepartment of Radiology, Pontificia Universidade Católica Do Rio Grande Do Sul, Av. Ipiranga, 6681, Porto Alegre, 90619900, Brazil.
Jorge A P NoronhaDepartment of Radiology, Pontificia Universidade Católica Do Rio Grande Do Sul, Av. Ipiranga, 6681, Porto Alegre, 90619900, Brazil.
Gustavo CarvalhalDepartment of Radiology, Pontificia Universidade Católica Do Rio Grande Do Sul, Av. Ipiranga, 6681, Porto Alegre, 90619900, Brazil.
Eurico J Dornelles NetoDepartment of Radiology, Pontificia Universidade Católica Do Rio Grande Do Sul, Av. Ipiranga, 6681, Porto Alegre, 90619900, Brazil.
Matheus ZanonDepartment of Radiology, Pontificia Universidade Católica Do Rio Grande Do Sul, Av. Ipiranga, 6681, Porto Alegre, 90619900, Brazil. mhgzanon@hotmail.com.ORCID http://orcid.org/0000-0001-7851-5125
Matteo BaldisserottoDepartment of Diagnostic Methods, Federal University of Health Sciences of Porto Alegre, R. Sarmento Leite, 245, Porto Alegre, 90050170, Brazil.
Bruno HochheggerDepartment of Radiology, Pontificia Universidade Católica Do Rio Grande Do Sul, Av. Ipiranga, 6681, Porto Alegre, 90619900, Brazil.
Pontifícia Universidade Católica do Rio Grande do Sul · BRUniversidade Federal do Rio Grande do Sul · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo evaluate the impact of the addition of quantitative apparent diffusion coefficient (ADC) data into the diagnostic performance of the Prostate Imaging Reporting and Data System version 2 (PI-RADSv2) scoring system to predict clinically significant prostate cancer (CSPCa).

methodsWe retrospectively included 91 consecutive patients who underwent prostate multiparametric magnetic resonance imaging (mp-MRI) and histopathological evaluation. Mp-MRI images were reported by the PI-RADSv2 scoring system and patients were divided into groups considering the likelihood of CSPCa. ADC value and ratio were obtained. Findings were correlated with histopathological data.

resultsCSPCa was found in 41.8% of cases (n = 38). PI-RADSv2 score 3-5 yielded a sensitivity of 97.4% (95% confidence intervals 86.5-99.5), a specificity of 50.9% (37.9-63.9), and AUC of 0.74 (0.67-0.81) to predict CSPCa. ADC value < 750 µm

conclusionQuantitative ADC data might not be beneficial to be used routinely in mp-MR imaging as criteria to detect clinically significant lesions due to the reduced sensitivity. Instead, when prostate lesions present a PI-RADSv2 score ≥ 3, additional quantitative ADC criteria can be helpful to increase the PI-RADS score specificity.

Indexed as

Diffusion Magnetic Resonance ImagingAgedData SystemsHumansMaleMiddle AgedProstatic NeoplasmsRetrospective StudiesApparent diffusion coefficientDiffusion magnetic resonance imagingMagnetic resonance imagingProstate cancerProstate Imaging Reporting and Data System version 2

Identifiers

PMID31175458
OpenAlexW2962071977

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.